Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Clinical Lung Cancer|December 31, 2005
Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancerNicholas W Choong, Everett E VokesExpert Opinion on Therapeutic Targets|November 16, 2006
Forthcoming receptor tyrosine kinase inhibitorsNicholas W Choong, Ezra E W CohenCritical Reviews in Oncology/Hematology|October 7, 2005
Epidermal growth factor receptor directed therapy in head and neck cancerNicholas W Choong, Ezra E W CohenClinical Lung Cancer|March 27, 2007
Key signaling pathways and targets in lung cancer therapyNicholas W Choong, Ravi Salgia, Everett E VokesExpert Opinion on Therapeutic Targets|June 14, 2005
Therapeutic targeting of receptor tyrosine kinases in lung cancerNicholas W Choong, Patrick C Ma, Ravi SalgiaJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2009
Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapyBen George, William J Wirostko, Thomas B Connor, et al.American Journal of Otolaryngology|September 16, 2011
Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasiaBrian T Brinkerhoff, Nicholas W Choong, Jonathan S Treisman, et al.Nature Clinical Practice. Oncology|January 13, 2006
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutationNicholas W Choong, Sascha Dietrich, Tanguy Y Seiwert, et al.Investigational New Drugs|August 4, 2009
Phase II study of sunitinib malate in head and neck squamous cell carcinomaNicholas W Choong, Mark Kozloff, David Taber, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancerNicholas W Choong, Ann M Mauer, Philip C Hoffman, et al.Pageof 2